GlassScriptPhysician profile
Abhishek Singla
NPI 1417237538
$593.15
in general payments reported to CMS, 2019-2025
8 companies · $379 in 2025
The $379 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.60 · 2022: $21.73 · 2024: $164 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.83 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $224.52 | 2025 | Nucala, Trelegy Ellipta |
| Mallinckrodt Hospital Products INC. | $122.30 | 2024-2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $98.41 | 2024 | Tezspire |
| Insmed, INC. | $55.57 | 2024-2025 | Arikayce, Brinsupri |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.60 | 2021 | |
| Janssen Biotech, INC. | $24.53 | 2024 | Tremfya |
| Merck Sharp & Dohme LLC | $21.73 | 2022 | |
| Verona Pharma, INC. | $17.49 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhishek Singla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.